Sign in to fuzzto save your conversations, follow your research and come back anytime.
Jyothy Laboratories
SectorFMCG
Jyothy Laboratories Ltd is an FMCG company founded in 1983 and incorporated in 1992. It manufactures and markets products in fabric care, dishwashing, household insecticides, and personal care categories. The company operates 25 manufacturing plants across 21 locations in India, with several ISO 9001-2015 certified units. Jyothy Labs' products are available in over 2.8 million outlets through various distribution channels. The company is divided into segments including Fabric Care, Dishwashing, Household Insecticides, Personal Care, and Others. Key brands include Ujala, Maxo, Exo, Margo, and Henko. The company has expanded through acquisitions, joint ventures, and product launches. In 2023, it merged with its wholly-owned subsidiary Jyothy Fabricare Services Limited. Jyothy Kallol Bangladesh Limited is a subsidiary of the company.
In the news
Jyothy Labs Q1 profit drops 51% to ₹47.6 crore, broker downgrades
Jyothy Labs shares up 1.70% as Elara cuts target price amid Exo expansion
Jyothy Labs: The Pril Exit and What It Means for Investors
Jyothy Labs shares fall 15% as Henkel ends Pril, Fa licence
Jyothy Labs shares crash 11% as Henkel ends Pril brand licensing
ICICI Securities recommends Jyothy Labs buy with ₹310 target
Jyothy Labs Q3: Revenue up 5.1% on volume growth, profit drops 7.3%
The Quarter story
The two most recent quarterly results, compared side-by-side.
Sales rebound in Q1 FY27, but profit margins face sharp compression amid controlled marketing spend and steady promoter backing.
Revenue rebounds from ₹717 Cr in Q4 FY26 to ₹773 Cr in Q1 FY27, signaling a top-line recovery.
EBITDA margin halves from 16.5% in Q1 FY26 to 8.4% in Q1 FY27, highlighting severe profitability pressure.
A&P intensity falls from 8.4% in Q2 FY26 to 6.5% in Q1 FY27, reflecting disciplined marketing budgeting.
PAT margin contracts from 12.9% in Q1 FY26 to 6.2% in Q1 FY27, underscoring a sharp bottom-line squeeze.
Public holding rises from 7.61% in Q1 FY26 to 10.18% in Q1 FY27, showing strong retail accumulation.
DII stake falls from 16.67% in Q2 FY26 to 14.21% in Q1 FY27, indicating domestic institutional caution.
Personal care business share recovers from 10% in Q4 FY26 to 12% in Q1 FY27, indicating category stabilization.
Gross margin slips from 48.0% in Q1 FY26 to 38.5% in Q1 FY27, reflecting mounting input cost pressures.
Main wash market share grows from 34% in Q1 FY26 to 36% in Q3 FY26, confirming steady category leadership.